Weathercast: Severe storms on Wilson's radar for Sunday
Dayna Brons, trainer for Humboldt Broncos, dies in hospital
United Kingdom organ donation numbers hit record levels in 2017-18
3rd person in IL dies after use of fake weed
Suit accuses 3 Spartans of sexual assault
Effectiveness of a group B outer membrane vesicle meningococcal vaccine against gonorrhea
12 July 2017, 12:30 | Violet Powell
People who got the meningitis vaccine in New Zealand"were significantly less likely to have gonorrhoea than people who did not get the shotMore
Finding the link between the two diseases was partly "a story of serendipity", says study coauthor Helen Petousis-Harris, a vaccinologist at the University of Auckland in New Zealand.
The sexually transmitted infection was previously proven to be resistant to medicine. "It does not need to be ideal", she added.
The vaccine was developed about 10 years ago to fight meningitis B. Among those vaccinated, cases of gonorrhea dropped by 31 percent.
Dr. Jean Longtin, head of the province's public health laboratory, said he and some colleagues chose to look at whether the vaccination campaign was having an impact on gonorrhea rates in that area after reading about an early observation from Norway.
The three-dose vaccine was introduced in 2004 in response to an epidemic strain of the meningococcal B bacterium, and New Zealand offered the vaccine free to anyone under the age of 20 between 2004 and 2006.
Petousis-Harris' group cautioned that the study population might differ from the general population in several respects.
Study co-author Professor Steven Black, from Cincinnati Children's Hospital in the USA, added: "The potential ability of an OMV group B meningococcal vaccine to provide even moderate protection against gonorrhoea would have substantial public health benefits in view of the prevalence of gonorrhoea, and the increase in antibiotic resistance".
The researchers collected data from 11 sexual health clinics in New Zealand representing nearly 15,000 people and around 1000 cases of gonorrhoea. It may be possible to eliminate many gonorrhoea infections using a vaccine with only moderate protection. "The disease rate was very high, and it was affecting a lot of people", said study co-author Dr. Steve Black of Cincinnati Children's Hospital.
"The potential ability of an OMV group B meningococcal vaccine to provide even moderate protection against gonorrhoea would have substantial public health benefits in view of the prevalence of gonorrhoea, and the increase in antibiotic resistance".
This case-control study looked at people with a gonorrhoea diagnosis and whether or not they'd had a meningitis vaccination in the past to see if there was an association.
Almost 15,000 people were included in the analysis.
Cases were defined as those with gonorrhea alone, while controls were those diagnosed with chlamydia alone.
The researchers found that people who had been vaccinated with the MeNZB vaccine were less likely to have gonorrhea than those who weren't (41 percent versus 51 percent).
"This paper is intriguing as a concept, but not as a reason to use this vaccine to protect people from gonorrhea", he said. The data came from 11 clinics in New Zealand.
The importance of preventing people developing a gonorrhoea infection is of mounting importance as the infection is getting much harder to treat.
Kramer said that if a vaccine against multiple strains of gonorrhea could be developed, it would be very beneficial.
Infected patients may experience discharge or pain while urinating, but around 10% of men and nearly half of women do not suffer any symptoms. Though it does have many similar components, we don't know if these are useful in protecting against gonorrhoea.
Philippines: Apex Court upholds martial law
Gringo Honasan, for his part, described the SC decision as "Philippine pluralistic democracy at work". Martial law will stay until the last terrorist is dead, the President told reporters in Bulacan.
Budget-Funding 'Head Count' Scheduled Today In Illinois House
Madigan said Saturday on the House floor that members will convene again Sunday, but no budget bills will be called before Monday. Their rates would increase from about $2,250 annually to about $2,970, depending on how many exemptions they claim.
Tesla's lower-priced Model 3 to start production Friday
The current share price indicate that stock is -21.25% away from its one year high and is moving 96.88% ahead of its 52-week low. August production "should be" 150 cars , he said , and he projected more than 1,500 of the vehicles will be made in September.
Total to sign $4.8B gas deal with Iran
The 20-year project that defies the U.S. pressure will eventually see the firms inject $4.9 billion. The state-owned China National Petroleum has a 30% stake, while Iran's Petropars has 19.9%.
Spider-Man: Homecoming - eve of release poster revealed
Mumbai: Robert Downey Jr says actor Tom Holland is "perfect" to play Spider-Man as the young star is physically quite gifted. The marketing team behind Spider-Man: Homecoming have had a rough time with the film's posters ahead of the film's release.